Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic

About this trial

The purpose of this clinical trial is to determine the impact of a home-based pulmonary rehabilitation program with health coaching on patient-reported respiratory-related quality of life and physical activity, as compared to usual care in patients with fibrotic interstitial lung disease.

Eligibility criteria

Qualifiers

F-ILD diagnosis, any disease subtype, active or prior medical treatment

>10% fibrosis on CT imaging

mMRC dyspnea score >1

All racial or ethnic categories, including non-English speakers (professional translators will be engaged to support screening, enrollment, and study participation)

Disqualifiers

Inability to walk (orthopedic/neurologic/cardiac limitation causing immobility)

Cognitive impairment or inability to understand and follow instructions

Traditional center-based PR completed within 3 months of initial study recruitment

Transition to hospice or end-of-life care at the time of screening

Trial design

Treatments tested in this trial

  • Home-based Pulmonary Rehab

Treatment groups

460 Participants
are divided into 2 treatment groups

Locations

4
Mayo Clinic in Arizona85259, ScottsdaleArizona, United States
Mayo Clinic in Florida32224, JacksonvilleFlorida, United States
University of Minnesota55455, MinneapolisMinnesota, United States
Mayo Clinic in Rochester55905, RochesterMinnesota, United States

Sponsors and collaborators

Mayo Clinic

Lead sponsor

Patient-Centered Outcomes Research Institute

Collaborator